NIH/National Institute of Allergy and Infectious Diseases
Model of pre-exposure prophylaxis against HIV forecasts benefits, potential cost-effectiveness
Published in AIDS Weekly, February 23rd, 2009
For every two people who begin treatment for HIV infection globally, five others become newly infected. Therefore, preventing new HIV infections is the foremost strategy for ending the HIV/AIDS epidemic. One potential prevention strategy involves giving antiretroviral drug regimens to people who are at high risk for HIV to protect them from infection. Important questions about this experimental approach, known as pre-exposure prophylaxis (PrEP), remain unanswered, including, Could PrEP cut the lifetime risk of HIV infection' Would PrEP be cost-effective'
A new mathematical model of PrEP use in U.S. populations at high risk for HIV infection takes these and other...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2009-02-23)
More Articles from AIDS Weekly
- Aethlon Medical, Inc.
Aethlon Medical Announces Expansion Into the Infectious Disease Diagnostic Market - HIV/AIDS
New HIV/AIDS study findings have been published by scientists at University of California - HIV/AIDS
New PRO2000 HIV-Prevention Findings Important Milestone on Path Toward Development of Effective Vaginal Microbicide - HIV/AIDS
Research from New York Blood Center reveals new findings on HIV/AIDS - HIV/AIDS
Scientists at Johns Hopkins University, Medical Department publish new data on HIV/AIDS - HIV/AIDS
University of Ottawa publishes research in HIV/AIDS - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
